CHICAGO, Dec. 20, 2017 -- Today, CERTUS™, innovators in food safety technologies, announced the expansion of its rapid food pathogen detection menu with the initiation of research and development of an Environmental Salmonella assay. To address a pathogen which, according to the CDC causes more than one million food-borne illnesses in the United States annually, the new CERTUS Salmonella test will use the same proprietary Surface Enhanced Raman Spectroscopy (SERS) technology and instrument platform as the company’s CERTUS EL test for Listeria, which is due to launch in early 2018. End-use benefits will similarly include extremely simple workflow, on-site testing capabilities, real-time growth monitoring, immediate alerts upon detection and bio-containment for the safety of the food processor and consumer. As with the CERTUS Listeria assay, the Salmonella test will be, “All-in one, all in-house.”
|
|||||
“CERTUS remains committed to developing tools to help food producers protect consumers from the world’s most dangerous pathogens,” says CERTUS President, John Coomes. “Salmonella continues to plague the food industry in large numbers, so we’re excited to develop an in-house solution for small and mid-sized food processing plants and address a true need in the market. Our customers will realize greater value with the CERTUS system now that they will be able to run both environmental Listeria and Salmonella in the same instrument.”
As with the CERTUS EL test, the CERTUS Salmonella assay is being designed to run in a single enrichment media, homogeneous no wash format. This means that no sample manipulation is required and that the assay tube never has to be opened once the sampling swab is inserted. The assay will be delivered in a Bio-Lock™ tube/cap design that cannot be opened after enrichment begins thus securing the environment from accidental contamination. This feature, combined with the target time-to-result goal of less than 24 hours, enables food producers to move testing on-site for significantly faster results.
Reagent research and development is being conducted in collaboration with CERTUS research partner, Solus Scientific, a UK-based food pathogen assay developer. Solus Scientific is the developer and manufacturer of their own Listeria, Salmonella and E. coli ELISA designed for large volume sample processing. Solus is also the assay development partner for the CERTUS EL assay used in the CERTUS System which is currently seeking AOAC validation.
ABOUT CERTUS™
CERTUS changes the way food safety testing is done, and helps reduce food-borne illness with a new generation of food pathogen detection devices and processes that are precise, affordable and easy to use. Making rapid pathogen detection and prevention Simple, Safe and Smart, CERTUS is built on the foundations of empowerment, simplicity, precision, and integrity. CERTUS seeks to integrate historically embraced values into future technology to bring innovation and expansive vision to the food safety industry. CERTUS joins the Toho Technology group of companies as a new brand specializing in Food Safety. Founded in 1819 in Nagoya, Japan, Toho is a privately-held company that provides engineering, manufacture, distribution and support of diverse industrial and life-science technologies to customers around the world. With significant expertise in precision instrumentation and equipment sales, Toho Technology advances the way products are made, tested and verified within the fields of food safety, healthcare, and nanotechnologies. The company currently operates multiple facilities in Chicago, Illinois; Japan; Shanghai, China and Jakarta, Indonesia. Toho Technology Inc. is the launch site for the CERTUS global expansion with all R&D, operations and sales centered in its Chicago location.
To learn more, visit http://CertusFoodSafety.com or call us at 872-810-4123.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/9a07c22e-b9a9-4708-81ab-3f679a2d84fc
Media Contact:
Candace Taylor
Email: [email protected]


Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 



